Total Payments
$48,800
2024 Payments
$15,823
Companies
8
Transactions
185
Medicare Patients
1,876
Medicare Billing
$118,361
Payment Breakdown by Category
Other$36,010 (73.8%)
Travel$6,470 (13.3%)
Food & Beverage$3,886 (8.0%)
Consulting$2,361 (4.8%)
Education$71.89 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25,275 | 26 | 51.8% |
| Compensation for serving as faculty or as a speaker for a medical education program | $8,850 | 9 | 18.1% |
| Travel and Lodging | $6,470 | 18 | 13.3% |
| Food and Beverage | $3,886 | 116 | 8.0% |
| Consulting Fee | $2,361 | 7 | 4.8% |
| Honoraria | $1,885 | 7 | 3.9% |
| Education | $71.89 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $23,542 | 88 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $13,396 | 32 | $0 (2024) |
| Madrigal Pharmaceuticals | $5,753 | 19 | $0 (2024) |
| ABBVIE INC. | $5,694 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $146.92 | 3 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $136.88 | 2 | $0 (2022) |
| Janssen Biotech, Inc. | $96.39 | 3 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $33.78 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,823 | 60 | Gilead Sciences, Inc. ($8,138) |
| 2023 | $10,550 | 49 | Gilead Sciences, Inc. ($5,644) |
| 2022 | $15,152 | 46 | Gilead Sciences, Inc. ($8,090) |
| 2021 | $7,274 | 30 | Intercept Pharmaceuticals, Inc. ($2,915) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.70 | General |
| 12/05/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $9.12 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $490.00 | General |
| Category: INFLAM | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $56.72 | General |
| Category: LIVER DISEASE | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.86 | General |
| 10/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.02 | General |
| 10/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $1.86 | General |
| 10/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $7.79 | General |
| Category: LIVER DISEASE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Gastroenterology | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $37.85 | General |
| Category: LIVER DISEASE | ||||||
| 10/03/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | Cash or cash equivalent | $17.43 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,890.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $254.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $209.48 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $186.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $94.62 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $77.39 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,620.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/25/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | In-kind items and services | $350.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Consulting Fee | In-kind items and services | $333.95 | General |
| Category: LIVER DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 383 | 411 | $61,620 | $23,761 |
| 2022 | 4 | 491 | 547 | $84,175 | $32,920 |
| 2021 | 4 | 498 | 559 | $79,020 | $34,212 |
| 2020 | 5 | 504 | 595 | $72,135 | $27,467 |
Total Patients
1,876
Total Services
2,112
Medicare Billing
$118,361
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 165 | 174 | $32,420 | $12,552 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 129 | 142 | $18,555 | $7,071 | 38.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $10,105 | $3,685 | 36.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 48 | 54 | $540.00 | $453.60 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 244 | $45,140 | $17,654 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 161 | $20,930 | $8,453 | 40.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 71 | 71 | $17,395 | $6,612 | 38.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 58 | 71 | $710.00 | $201.92 | 28.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 193 | 225 | $39,725 | $18,109 | 45.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 176 | 189 | $23,040 | $9,954 | 43.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 63 | 63 | $15,435 | $5,906 | 38.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 66 | 82 | $820.00 | $243.31 | 29.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 151 | 182 | $30,030 | $11,414 | 38.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 179 | 208 | $23,920 | $9,194 | 38.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 67 | 67 | $16,090 | $6,219 | 38.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 96 | 127 | $1,270 | $376.20 | 29.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 11 | 11 | $825.00 | $263.98 | 32.0% |
About Yvonne Fuller-Fontenot, F.N.P
Yvonne Fuller-Fontenot, F.N.P is a Family healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861422362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yvonne Fuller-Fontenot, F.N.P has received a total of $48,800 in payments from pharmaceutical and medical device companies, with $15,823 received in 2024. These payments were reported across 185 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($25,275).
As a Medicare-enrolled provider, Fuller-Fontenot has provided services to 1,876 Medicare beneficiaries, totaling 2,112 services with total Medicare billing of $118,361. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Albany, NY
- Active Since 07/03/2006
- Last Updated 10/29/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1861422362
Products in Payments
- Epclusa (Drug) $17,786
- OCALIVA (Drug) $13,396
- REZDIFFRA (Drug) $5,671
- MAVYRET (Drug) $2,466
- Livdelzi (Drug) $490.00
- RINVOQ (Biological) $387.41
- SKYRIZI (Biological) $194.31
- DUPIXENT (Biological) $146.92
- CREON (Drug) $102.84
- RESMETIROM (Drug) $82.34
- STELARA (Biological) $67.00
- XIFAXAN (Drug) $33.78
- REMICADE (Biological) $29.39
- KANUMA (Biological) $22.61
- LINZESS (Drug) $19.69
- HUMIRA (Biological) $14.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Albany
Lisa Armao, Anp, ANP
Family — Payments: $61,953
Family $61,953
Elvira Faw, Np, NP
Family — Payments: $12,359
Family $12,359
Rodney Siau, Fnp-C, FNP-C
Family — Payments: $11,071
Family $11,071
Mrs. Jennifer Berry, Np, NP
Family — Payments: $8,911
Family $8,911
Melissa Stevenson
Family — Payments: $7,718
Family $7,718
Ms. Lindsay Gaetani, Np, NP
Family — Payments: $7,559
Family $7,559